Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design

American Journal of Ophthalmology

Volumn 154, Issue 3, 2012, Pages

  McCarthy, Linda C ^a   Newcombe, Paul J ^a   Whittaker, John C ^a   Wurzelmann, John I ^b   Fries, Michael A ^b   Burnham, Nancy R ^b   Cai, Gengqian ^b   Stinnett, Sandra W ^b   Trivedi, Trupti M ^b   Xu, Chun Fang ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A69S GENE; AGE RELATED EYE DISEASE STUDY SIMPLIFIED SEVERITY SCALE; ARMS2 GENE; ARTICLE; BAYES THEOREM; CFH GENE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC MARKER; GENETIC RISK; GEOGRAPHIC ATROPHY; HUMAN; INCIDENCE; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STUDY DESIGN; SUBRETINAL NEOVASCULARIZATION; VALIDATION PROCESS; Y402H GENE;

EID: 84865812438     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.03.021     Document Type: Article

References (60)

1. C. Bunce, R. Wormald Causes of blind certifications in England and Wales: April 1999-March 2000 Eye (Lond) 22 7 2008 905 911
2. N. Congdon, B. O'Colmain, C.C. Klaver Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 4 2004 477 485
3. E. Gunnlaugsdottir, A. Arnarsson, F. Jonasson Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study Acta Ophthalmol 86 7 2008 778 785
4. L. Xu, Y. Wang, Y. Li Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study Ophthalmology 113 7 2006 1134
5. P.J. Rosenfeld, D.M. Brown, J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
6. D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
7. R.L. Avery, D.J. Pieramici, M.D. Rabena, A.A. Castellarin, M.A. Nasir, M.J. Giust Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 3 2006 363 372
8. D.F. Martin, M.G. Maguire, G.S. Ying, J.E. Grunwald, S.L. Fine, G.J. Jaffe Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
9. S.C. Tomany, J.J. Wang, R. van Leeuwen Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 7 2004 1280 1287
10. R. Kawasaki, M. Yasuda, S.J. Song et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis Ophthalmology 117 5 2010 921 927
11. Y. Chen, M. Bedell, K. Zhang Age-related macular degeneration: genetic and environmental factors of disease Mol Interv 10 5 2010 271 281
12. R.J. Klein, C. Zeiss, E.Y. Chew Complement factor H polymorphism in age-related macular degeneration Science 308 5720 2005 385 389
13. P.J. Francis, H. Zhang, A. Dewan, J. Hoh, M.L. Klein Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population Mol Vis 14 2008 1395 1400
14. A. Rivera, S.A. Fisher, L.G. Fritsche Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk Hum Mol Genet 14 21 2005 3227 3236
15. B. Gold, J.E. Merriam, J. Zernant Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration Nat Genet 38 4 2006 458 462
16. J.R. Yates, T. Sepp, B.K. Matharu Complement C3 variant and the risk of age-related macular degeneration N Engl J Med 357 6 2007 553 561
17. W. Chen, D. Stambolian, A.O. Edwards Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration Proc Natl Acad Sci U S A 107 16 2010 7401 7406
18. J.M. Lin, L. Wan, Y.Y. Tsai Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration Am J Ophthalmol 145 6 2008 1045 1051
19. B.M. Neale, J. Fagerness, R. Reynolds Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) Proc Natl Acad Sci U S A 107 16 2010 7395 7400
20. Y. Yu, T.R. Bhangale, J. Fagerness Common Variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration Hum Mol Genet 20 18 2011 3699 3709
21. M. Yasuda, Y. Kiyohara, Y. Hata Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study Ophthalmology 116 11 2009 2135 2140
22. T.E. Clemons, R.C. Milton, R. Klein, J.M. Seddon, F.L. Ferris III Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19 Ophthalmology 112 4 2005 533 539
23. J.P. Sangiovanni, E.Y. Chew, E. Agron The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 Arch Ophthalmol 126 9 2008 1274 1279
24. J.S. Tan, P. Mitchell, A. Kifley, V. Flood, W. Smith, J.J. Wang Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Arch Ophthalmol 125 8 2007 1089 1095
25. S.J. Chen, C.Y. Cheng, K.L. Peng Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study Invest Ophthalmol Vis Sci 49 7 2008 3126 3133
26. F.L. Ferris, M.D. Davis, T.E. Clemons A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 11 2005 1570 1574
27. J.M. Seddon, P.J. Francis, S. George, D.W. Schultz, B. Rosner, M.L. Klein Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration JAMA 297 16 2007 1793 1800
28. J.M. Seddon, R. Reynolds, J. Maller, J.A. Fagerness, M.J. Daly, B. Rosner Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables Invest Ophthalmol Vis Sci 50 5 2009 2044 2053
29. R. Reynolds, M.E. Hartnett, J.P. Atkinson, P.C. Giclas, B. Rosner, J.M. Seddon Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes Invest Ophthalmol Vis Sci 50 12 2009 5818 5827
30. J. Jakobsdottir, Y.P. Conley, D.E. Weeks, R.E. Ferrell, M.B. Gorin C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes PLoS One 3 5 2008 e2199
31. J. Gibson, A. Cree, A. Collins, A. Lotery, S. Ennis Determination of a gene and environment risk model for age-related macular degeneration Br J Ophthalmol 94 10 2010 1382 1387
32. K.L. Spencer, L.M. Olson, N. Schnetz-Boutaud Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration PLoS One 6 3 2011 e17784
33. M.L. Klein, P.J. Francis, F.L. Ferris III, S.C. Hamon, T.E. Clemons Risk assessment model for development of advanced age-related macular degeneration Arch Ophthalmol 129 12 2011 1543 1550
34. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study (AREDS): design implications AREDS report no. 1 Control Clin Trials 20 6 1999 573 600
35. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants - Age-Related Eye Disease Study Report No. 2 J Nutr 130 5S Suppl 2000 1516S 1519S
36. Age-Related Eye Diseases Study database, via dbGaP accession number phs000001.v2.p1 http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap Accessed August 12, 2010
37. M.D. Davis, R.E. Gangnon, L.Y. Lee The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol 123 11 2005 1484 1498
38. C.E. Metz Basic principles of ROC analysis Semin Nucl Med 8 4 1978 283 298
39. J.A. Hanley, B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1 1982 29 36
40. T. Hastie, R. Tibshirani, J. Friedman The Elements of Statistical Learning: Data Mining, Inference, and Prediction Springer Series in Statistics 2nd ed. 2011 Springer New York 241 248
41. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 3 1988 837 845
42. M.A. Brantley Jr, A.M. Fang, J.M. King, A. Tewari, S.M. Kymes, A. Shiels Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab Ophthalmology 114 12 2007 2168 2173
43. A.Y. Lee, A.K. Raya, S.M. Kymes, A. Shiels, M.A. Brantley Jr Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab Br J Ophthalmol 93 5 2009 610 613
44. C. Nischler, H. Oberkofler, C. Ortner et al. Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration Acta Ophthalmol 89 4 2011 e344 e349
45. S.J. Teper, A. Nowinska, J. Pilat, A. Palucha, E. Wylegala Involvement of genetic factors in the response to a variable-dosing ranibizumab treatment regimen for age-related macular degeneration Mol Vis 16 2010 2598 2604
46. B. Kloeckener-Gruissem, D. Barthelmes, S. Labs et al. Genetic association with response to intravitreal ranibizumab (Lucentis(R)) in neovascular AMD patients Invest Ophthalmol Vis Sci 852 7 2011 4694 4702
47. R. Reynolds, B. Rosner, J.M. Seddon Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration Ophthalmology 117 10 2010 1989 1995
48. J. Jakobsdottir, M.B. Gorin, Y.P. Conley, R.E. Ferrell, D.E. Weeks Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers PLoS Genet 5 2 2009 e1000337
49. A.E. Hughes, N. Orr, C. Patterson Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking PLoS Med 4 12 2007 e355
50. I.A. Barbazetto, N. Saroj, H. Shapiro, P. Wong, A.C. Ho, K.B. Freund Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials Am J Ophthalmol 149 6 2010 939 946
51. L.D. Hubbard, R.P. Danis, M.W. Neider Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2 Invest Ophthalmol Vis Sci 49 8 2008 3269 3282
52. M.D. Davis, R.E. Gangnon, L.Y. Lee The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol 123 11 2005 1484 1498
53. F.L. Ferris, M.D. Davis, T.E. Clemons A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 11 2005 1570 1574
54. J.F. Lawless Statistical Models and Methods for Lifetime Data 2nd ed. 2003 Wiley-Interscience Hoboken
55. P.J. Green Reversible jump Markov chain Monte Carlo computation and Bayesian model determination Biometrika 82 4 1995 711
56. D.J. Lunn, J.C. Whittaker, N. Best A Bayesian toolkit for genetic association studies Genet Epidemiol 30 3 2006 231 247
57. W.R. Gilks, S. Richardson, D. Spiegelhalter Markov Chain Monte Carlo in Practice 1995 Chapman & Hall London
58. D.J. Spiegelhalter, N.G. Best Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling Stat Med 22 23 2003 3687 3709
59. A. Gelman, X.L. Meng, H. Stern Posterior predictive assessment of model fitness via realized discrepancies Statistica Sinica 6 1996 733 759
60. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 3 1988 837 845